The drug enhances insulin secretion from pancreatic beta cells in a glucose-dependent manner, meaning it stimulates insulin release only when blood glucose levels are elevated
"Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis." Nature Medicine , 28(3), 591-598
A new personalized formula, compounded tirzepatide with vitamin B12, is now available for those who experience side effects while taking tirzepatide
These track disease activity and catch early signs of flare or organ involvement
Common side effects (5% or more of patients) Nausea, diarrhea, vomiting, constipation, abdominal pain, decreased appetite, indigestion, injection site reactions Serious side effects (rare) Pancreatitis stop Zepbound and seek emergency care for severe, persistent abdominal pain radiating to the back Gallbladder disease upper right abdominal pain, fever, jaundice Severe allergic reactions facial swelling, throat tightening, difficulty breathing Acute kidney injury usually from dehydration due to prolonged vomiting or diarrhea Hypoglycemia most likely when combined with insulin or sulfonylureas in diabetic patients Increased resting heart rate Boxed warning: Tirzepatide caused thyroid C-cell tumors in animal studies
